The role of matrix metalloproteinase-2 in the metastatic cascade: a review

Nigel P. Murray

DOI: https://doi.org/10.1515/oncologie-2023-0368

2024-01-01

ONCOLOGIE

Abstract:Abstract Matrix metalloproteinase-2 (MMP-2) is a gelatinase and is involved in multiple steps of the metastatic cascade. More than a decade ago an increased expression of MMP-2 in tumour cells or higher serum levels was reported to be a prognostic biomarker for a lower disease-free and overall survival rate. In recent years new evidence has indicated that MMP-2 has an important role in the tumour ecosystem. It is one of the many players in the onco-sphere, involved in interacting between tumour cells, host cells and the microenvironment. It plays a role in the dissemination of tumour cells, the epithelial–mesenchymal and mesenchymal–epithelial transitions, the formation of the pre-metastatic and metastatic niches, dormancy of tumour cells and modulating the immune system. The aim of this review is to highlight these multiple roles in the metastatic cascade and how many signalling pathways can up or down-regulate MMP-2 activity in the different stages of cancer progression and the effect of MMP-2 on the onco-sphere. Research in head and neck cancer is used as an example of these processes. The use of non-specific MMP inhibitors has been unsuccessful showing only limited benefits and associated with high toxicity as such that none have progressed past Phase III trials. Preclinical trials are undergoing using antibodies directed against specific matrix metalloproteinases, these targeted therapies may be potentially less toxic to the patients.

oncology

What problem does this paper attempt to address?

The paper primarily explores the various roles of Matrix metalloproteinase-2 (MMP-2) in the process of tumor metastasis. MMP-2 is a type of collagenase that plays a crucial role in different stages of tumor metastasis. Specifically, MMP-2 is involved in the following processes:

1. **As a prognostic biomarker**: Early studies have shown that increased expression of MMP-2 in tumor cells or elevated serum levels are associated with poorer disease-free survival and overall survival rates.

2. **Role in the tumor ecosystem**: MMP-2 is a key player in the tumor ecosystem, mediating interactions between tumor cells, host cells, and the microenvironment.

3. **Dissemination of tumor cells**: MMP-2 promotes the detachment of tumor cells from the primary site and their entry into the bloodstream, lymphatic system, or adjacent tissues by degrading the basement membrane and extracellular matrix (ECM).

4. **Epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET)**: MMP-2 is involved in regulating the EMT process of tumor cells, increasing their invasiveness and migratory capacity; when tumor cells implant in distant tissues, they may undergo MET to form new tumors.

5. **Formation of pre-metastatic and metastatic niches**: MMP-2 remodels the microenvironment of distant tissues, providing favorable conditions for circulating tumor cells to implant.

6. **Dormancy of tumor cells**: MMP-2 is not only related to the entry of tumor cells into a dormant state but may also be involved in regulating the awakening of tumor cells from dormancy.

Additionally, the paper discusses the limitations and toxicity issues of non-specific inhibitors targeting MMP-2 in clinical trials and suggests that therapies targeting specific MMPs may be more effective and have fewer side effects.

In summary, this review article aims to highlight the multiple roles of MMP-2 in the process of tumor metastasis and discusses various signaling pathways that affect MMP-2 activity and their impact on the tumor ecosystem.